Saba Jalalifar
Overview
Explore the profile of Saba Jalalifar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
424
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jalalifar S, Razavi S, Mirzaei R, Irajian G, Pooshang Bagheri K
Front Microbiol
. 2024 Feb;
14:1269392.
PMID: 38370578
Background: The emergence and rapid spread of multi-drug resistant (MDR) bacterial strains, such as methicillin-resistant (MRSA) and vancomycin-resistant (VRSA), have posed a significant challenge to the medical community due to...
2.
Jalalifar S, Morovati Khamsi H, Hosseini-Fard S, Karampoor S, Bajelan B, Irajian G, et al.
Infect Agent Cancer
. 2023 Feb;
18(1):6.
PMID: 36732833
No abstract available.
3.
Jalalifar S, Morovati Khamsi H, Hosseini-Fard S, Karampoor S, Bajelan B, Irajian G, et al.
Infect Agent Cancer
. 2023 Jan;
18(1):3.
PMID: 36658631
The role of gut microbiota and its products in human health and disease is profoundly investigated. The communication between gut microbiota and the host involves a complicated network of signaling...
4.
Jalalifar S, Mirzaei R, Motallebirad T, Razavi S, Talebi M
Biomed Res Int
. 2023 Jan;
2022:4959487.
PMID: 36605101
Background: Methicillin-resistant (MRSA) is one of the main bacterial pathogens causing chronic infections, mainly because of its capacity to produce biofilm. Biofilm production is one of the underlying strategies for...
5.
Mirzaei R, Sholeh M, Jalalifar S, Zafari E, Kazemi S, Rasouli-Saravani A, et al.
Microb Pathog
. 2021 Jul;
158:105115.
PMID: 34332069
In recent years, extreme attention has been focused on the role of immunometabolism in the regulation of immune cell responses in healthy individuals during infection, autoimmunity, and cancer. In the...
6.
Mirzaei R, Bouzari B, Hosseini-Fard S, Mazaheri M, Ahmadyousefi Y, Abdi M, et al.
Biomed Pharmacother
. 2021 Jul;
139:111661.
PMID: 34243604
During the past decade, accumulating evidence from the research highlights the suggested effects of bacterial communities of the human gut microbiota and their metabolites on health and disease. In this...
7.
Mirzaei R, Zamani F, Hajibaba M, Rasouli-Saravani A, Noroozbeygi M, Gorgani M, et al.
J Neuroimmunol
. 2021 Jul;
358:577640.
PMID: 34224949
Exosomes are a nano-vesicle surrounded by a bilipid layer that can release from almost all cells and could be detected in tissues and biological liquids. These vesicles contain lipids, proteins,...
8.
Mirzaei R, Attar A, Papizadeh S, Jeda A, Hosseini-Fard S, Jamasbi E, et al.
Arch Virol
. 2021 May;
166(7):1841.
PMID: 33982181
No abstract available.
9.
Motallebirad T, Fazeli H, Ghahiri A, Shokri D, Jalalifar S, Moghim S, et al.
BMC Microbiol
. 2021 May;
21(1):139.
PMID: 33947330
Background: The information on antibiotic resistance and molecular features of Group B Streptococcus (GBS) are essential for epidemiological purposes as well as vaccine development. Therefore, we aimed to assess the...
10.
The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19)
Mirzaei R, Attar A, Papizadeh S, Jeda A, Hosseini-Fard S, Jamasbi E, et al.
Arch Virol
. 2021 Mar;
166(7):1819-1840.
PMID: 33745067
COVID-19 is an acute respiratory infection accompanied by pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has affected millions of people globally. To date, there are no...